Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides
Conditions
Interventions
bexarotene
methoxypsoralen
+1 more
Locations
28
Austria
Karl-Franzens-University Graz
Graz, Austria
Allgemeines Krankenhaus - Universitatskliniken
Vienna, Austria
Ghent University
Ghent, Belgium
U.Z. Gasthuisberg
Leuven, Belgium
Bispebjerg Hospital
Copenhagen, Denmark
Helsinki University Central Hospital
Helsinki, Finland
Start Date
January 1, 2003
Primary Completion Date
May 1, 2010
Completion Date
June 1, 2011
Last Updated
July 9, 2018
NCT06263491
NCT06337318
NCT05529069
NCT07388563
NCT05139017
NCT07350863
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions